Luka Kulic

2.7k total citations
40 papers, 1.4k citations indexed

About

Luka Kulic is a scholar working on Physiology, Molecular Biology and Neurology. According to data from OpenAlex, Luka Kulic has authored 40 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Physiology, 17 papers in Molecular Biology and 11 papers in Neurology. Recurrent topics in Luka Kulic's work include Alzheimer's disease research and treatments (27 papers), Neuroinflammation and Neurodegeneration Mechanisms (9 papers) and Dementia and Cognitive Impairment Research (5 papers). Luka Kulic is often cited by papers focused on Alzheimer's disease research and treatments (27 papers), Neuroinflammation and Neurodegeneration Mechanisms (9 papers) and Dementia and Cognitive Impairment Research (5 papers). Luka Kulic collaborates with scholars based in Switzerland, Germany and United States. Luka Kulic's co-authors include Roger M. Nitsch, Maria Teresa Ferretti, Mario Merlini, Tunahan Kirabali, Claudia Späni, Tobias Welt, Tobias Suter, Christian Tackenberg, Stanley I. Rapoport and Gene E. Alexander and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Luka Kulic

38 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luka Kulic Switzerland 23 732 467 440 205 173 40 1.4k
Jeffrey L. Frost United States 15 708 1.0× 700 1.5× 356 0.8× 188 0.9× 216 1.2× 18 1.5k
Dieu‐Trang Fuchs United States 19 609 0.8× 456 1.0× 387 0.9× 117 0.6× 124 0.7× 34 1.4k
Frédérique Bard United States 16 1.0k 1.4× 652 1.4× 450 1.0× 162 0.8× 281 1.6× 25 1.6k
Michael A. Mastrangelo United States 21 968 1.3× 717 1.5× 558 1.3× 234 1.1× 298 1.7× 27 1.8k
Ilie‐Cosmin Stancu Belgium 14 992 1.4× 511 1.1× 696 1.6× 167 0.8× 293 1.7× 17 1.5k
Mary Lou Previti United States 18 930 1.3× 591 1.3× 409 0.9× 82 0.4× 236 1.4× 27 1.5k
Ernesto R. Gonzales United States 19 608 0.8× 486 1.0× 396 0.9× 70 0.3× 231 1.3× 29 1.5k
Lingzhi Zhao United States 11 520 0.7× 428 0.9× 260 0.6× 73 0.4× 321 1.9× 12 1.1k
Kevin X. Le United States 11 588 0.8× 673 1.4× 297 0.7× 149 0.7× 321 1.9× 15 1.3k
Mario Merlini United States 15 604 0.8× 1.0k 2.2× 345 0.8× 188 0.9× 240 1.4× 27 1.8k

Countries citing papers authored by Luka Kulic

Since Specialization
Citations

This map shows the geographic impact of Luka Kulic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luka Kulic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luka Kulic more than expected).

Fields of papers citing papers by Luka Kulic

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luka Kulic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luka Kulic. The network helps show where Luka Kulic may publish in the future.

Co-authorship network of co-authors of Luka Kulic

This figure shows the co-authorship network connecting the top 25 collaborators of Luka Kulic. A scholar is included among the top collaborators of Luka Kulic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luka Kulic. Luka Kulic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Klein, Gregory, Tobias Bittner, Daria Rukina, et al.. (2025). Interim biomarker results for trontinemab, a novel Brainshuttle™ antibody in development for the treatment of Alzheimer’s disease. Alzheimer s & Dementia. 21(S5). e104288–e104288.
2.
Mallone, Anna, Colin Sparano, Tunahan Kirabali, et al.. (2025). Altered T-cell reactivity in the early stages of Alzheimer's disease. Brain. 148(9). 3364–3378. 2 indexed citations
3.
Kulic, Luka, Gregory Klein, Carsten Hofmann, et al.. (2025). Latest results from the dose‐expansion part (Part 2) of the Brainshuttle™ AD study of trontinemab in people with Alzheimer’s disease. Alzheimer s & Dementia. 21(S5). e104293–e104293.
4.
Kirabali, Tunahan, Anna Mallone, Luka Kulic, et al.. (2023). Early β‐amyloid accumulation in the brain is associated with peripheral T cell alterations. Alzheimer s & Dementia. 19(12). 5642–5662. 14 indexed citations
5.
Åkerman, Sigvard, Jana Felicitas Schulz, Luka Kulic, et al.. (2023). Mechanisms of amyloid-β34 generation indicate a pivotal role for BACE1 in amyloid homeostasis. Scientific Reports. 13(1). 2216–2216. 10 indexed citations
6.
Ni, Ruiqing, Yvette Zarb, Gisela Kuhn, et al.. (2020). SWI and phase imaging reveal intracranial calcifications in the P301L mouse model of human tauopathy. Magnetic Resonance Materials in Physics Biology and Medicine. 33(6). 769–781. 15 indexed citations
7.
Rust, Ruslan, Tunahan Kirabali, Lisa Grönnert, et al.. (2020). A Practical Guide to the Automated Analysis of Vascular Growth, Maturation and Injury in the Brain. Frontiers in Neuroscience. 14. 244–244. 31 indexed citations
8.
Kulic, Luka, Charlotte E. Teunissen, Adeola Shobo, et al.. (2019). Aβ34 is a BACE1-derived degradation intermediate associated with amyloid clearance and Alzheimer’s disease progression. Nature Communications. 10(1). 2240–2240. 47 indexed citations
9.
Ni, Ruiqing, Diana Kindler, Roger M. Nitsch, et al.. (2019). fMRI Reveals Mitigation of Cerebrovascular Dysfunction by Bradykinin Receptors 1 and 2 Inhibitor Noscapine in a Mouse Model of Cerebral Amyloidosis. Frontiers in Aging Neuroscience. 11. 27–27. 24 indexed citations
10.
Maier, Marcel, Tobias Welt, Fabio Montrasio, et al.. (2018). A human-derived antibody targets misfolded SOD1 and ameliorates motor symptoms in mouse models of amyotrophic lateral sclerosis. Science Translational Medicine. 10(470). 58 indexed citations
11.
Merlini, Mario, Tunahan Kirabali, Luka Kulic, Roger M. Nitsch, & Maria Teresa Ferretti. (2018). Extravascular CD3+ T Cells in Brains of Alzheimer Disease Patients Correlate with Tau but Not with Amyloid Pathology: An Immunohistochemical Study. Neurodegenerative Diseases. 18(1). 49–56. 135 indexed citations
12.
Doorn, Linda Josephine Christine van Waalwijk van, Luka Kulic, Marleen J.A. Koel‐Simmelink, et al.. (2017). Multicenter Analytical Validation of Aβ40 Immunoassays. Frontiers in Neurology. 8. 310–310. 9 indexed citations
13.
Grandjean, Joanes, Luka Kulic, Tobias Welt, et al.. (2016). Complex interplay between brain function and structure during cerebral amyloidosis in APP transgenic mouse strains revealed by multi-parametric MRI comparison. NeuroImage. 134. 1–11. 32 indexed citations
14.
Camici, Giovanni G., Remo D. Spescha, Tobias Welt, et al.. (2016). Genetic ablation of the p66Shc adaptor protein reverses cognitive deficits and improves mitochondrial function in an APP transgenic mouse model of Alzheimer’s disease. Molecular Psychiatry. 22(4). 605–614. 28 indexed citations
15.
Kulic, Luka, et al.. (2016). High-speed video gait analysis reveals early and characteristic locomotor phenotypes in mouse models of neurodegenerative movement disorders. Behavioural Brain Research. 311. 340–353. 34 indexed citations
16.
Keskitalo, Salla, Anita Szodorai, Luka Kulic, et al.. (2014). Reciprocal modulation of Aβ42 aggregation by copper and homocysteine. Frontiers in Aging Neuroscience. 6. 237–237. 9 indexed citations
17.
Keskitalo, Salla, Desirée E.C. Smith, Alexander Semmler, et al.. (2013). Hyperhomocysteinemia in Alzheimer's Disease: The Hen and the Egg?. Journal of Alzheimer s Disease. 33(4). 1097–1104. 25 indexed citations
18.
Chadha, Antonella Santuccione, Mario Merlini, Christian Tackenberg, et al.. (2012). Active vaccination with ankyrin G reduces β-amyloid pathology in APP transgenic mice. Molecular Psychiatry. 18(3). 358–368. 23 indexed citations
19.
Kulic, Luka, M. Axel Wollmer, Virginie Rhein, et al.. (2009). Combined expression of tau and the Harlequin mouse mutation leads to increased mitochondrial dysfunction, tau pathology and neurodegeneration. Neurobiology of Aging. 32(10). 1827–1838. 26 indexed citations
20.
Teipel, Stefan, Gene E. Alexander, Diane Teichberg, et al.. (2002). Progression of Corpus Callosum Atrophy in Alzheimer Disease. Archives of Neurology. 59(2). 243–243. 143 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026